Filing Details
- Accession Number:
- 0001384101-25-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-06 16:41:55
- Reporting Period:
- 2025-03-04
- Filing Date:
- 2025-03-06
- Accepted Time:
- 2025-03-06 16:41:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1539796 | Marc Stapley | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-03-04 | 28,189 | $32.82 | 292,543 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-03-04 | 23,414 | $33.91 | 269,129 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-03-04 | 1,094 | $34.37 | 268,035 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024.
- Represents weighted average sales price. Sale prices for the transactions range from $32.27 to $33.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $33.28 to $34.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $34.29 to $34.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.